[Seizures and recurrent left hemiparesia (clinical conference)].
Hoang-Xuan
K
K
Fédération de Neurologie Mazarin, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
Dairou
R
R
Gray
F
F
Sellal
F
F
D020016:Activated Protein C Resistance / Q000150:complications / Q000235:genetics; D000368:Aged; D001921:Brain / Q000473:pathology*; D001932:Brain Neoplasms / Q000150:complications / Q000175:diagnosis / Q000473:pathology*; D003428:Cross Infection / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003937:Diagnosis, Differential; D018792:Encephalitis, Viral / Q000175:diagnosis / Q000188:drug therapy; D004827:Epilepsy / Q000209:etiology / Q000473:pathology*; D005165:Factor V / Q000235:genetics; D017809:Fatal Outcome; D006579:Heterozygote; D006801:Humans; D020767:Intracranial Thrombosis / Q000175:diagnosis; D008279:Magnetic Resonance Imaging; D008297:Male; D018302:Neoplasms, Neuroepithelial / Q000150:complications / Q000175:diagnosis / Q000473:pathology*; D010291:Paresis / Q000209:etiology / Q000473:pathology*; D012008:Recurrence; D003294:Seizures, Febrile / Q000209:etiology; D013788:Thalamus / Q000473:pathology
C095381:factor V Leiden; D005165:Factor V